ENDONOVO THERAPEUTICS, INC. Amortization
ENDONOVO THERAPEUTICS, INC. (ENDV) reported Amortization of $161.73 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-22.
Discontinued › Cash Flow › Operating Activities
us-gaap:AdjustmentForAmortization · last filed 2023-05-22
- ENDONOVO THERAPEUTICS, INC. amortization for the quarter ending 2023-03-31 was $161.73K, a 0.00% change year-over-year.
- ENDONOVO THERAPEUTICS, INC. amortization for the quarter ending 2022-03-31 was $161.73K.
- ENDONOVO THERAPEUTICS, INC. amortization for the quarter ending 2019-12-31 was $161.73K, a 0.00% change year-over-year.
- ENDONOVO THERAPEUTICS, INC. amortization for the quarter ending 2019-09-30 was $161.73K, a 0.00% change year-over-year.
- ENDONOVO THERAPEUTICS, INC. amortization for fiscal 2019 was $646.91K, a 0.00% change from fiscal 2018.
- ENDONOVO THERAPEUTICS, INC. amortization for fiscal 2018 was $646.91K.
- ENDONOVO THERAPEUTICS, INC. amortization for fiscal 2017 was $0.00.
| Period end | Amortization 3 month | Amortization 6 month | Amortization 9 month | Amortization 12 month |
|---|---|---|---|---|
| 2023-03-31 | $161.73K 10-Q · filed 2023-05-22 | |||
| 2022-03-31 | $161.73K 10-Q · filed 2023-05-22 | |||
| 2019-12-31 | $161.73K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-04 | $323.45K derived: sum of 2 quarters · filed 2020-05-04 | $485.18K derived: sum of 3 quarters · filed 2020-05-04 | $646.91K 10-K · filed 2020-05-04 |
| 2019-09-30 | $161.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-19 | $323.46K derived: sum of 2 quarters · filed 2019-11-19 | $485.18K 10-Q · filed 2019-11-19 | $646.91K derived: sum of 4 quarters · filed 2020-05-04 |
| 2019-06-30 | $161.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $323.45K 10-Q · filed 2019-08-13 | $485.18K derived: sum of 3 quarters · filed 2020-05-04 | $646.91K derived: sum of 4 quarters · filed 2020-05-04 |
| 2019-03-31 | $161.73K 10-Q · filed 2019-05-09 | $323.45K derived: sum of 2 quarters · filed 2020-05-04 | $485.18K derived: sum of 3 quarters · filed 2020-05-04 | $646.91K derived: sum of 4 quarters · filed 2020-05-04 |
| 2018-12-31 | $161.73K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-04 | $323.45K derived: sum of 2 quarters · filed 2020-05-04 | $485.18K derived: sum of 3 quarters · filed 2020-05-04 | $646.91K 10-K · filed 2020-05-04 |
| 2018-09-30 | $161.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-19 | $323.45K derived: sum of 2 quarters · filed 2019-11-19 | $485.18K 10-Q · filed 2019-11-19 | $485.18K derived: sum of 4 quarters · filed 2019-11-19 |
| 2018-06-30 | $161.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $323.45K 10-Q · filed 2019-08-13 | $323.45K derived: sum of 3 quarters · filed 2019-08-13 | $323.45K derived: sum of 4 quarters · filed 2019-08-13 |
| 2018-03-31 | $161.73K 10-Q · filed 2018-05-18 | $161.73K derived: sum of 2 quarters · filed 2019-04-15 | $161.73K derived: sum of 3 quarters · filed 2019-04-15 | $161.73K derived: sum of 4 quarters · filed 2019-04-15 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-15 | $0.00 derived: sum of 2 quarters · filed 2019-04-15 | $0.00 derived: sum of 3 quarters · filed 2019-04-15 | $0.00 10-K · filed 2019-04-15 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $0.00 derived: sum of 2 quarters · filed 2018-11-13 | $0.00 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $0.00 10-Q · filed 2018-08-13 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-18 |